Form 8-K - Current report:
SEC Accession No. 0001641172-25-011452
Filing Date
2025-05-19
Accepted
2025-05-19 16:15:28
Documents
12
Period of Report
2025-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46097
  Complete submission text file 0001641172-25-011452.txt   212555

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20250519.xsd EX-101.SCH 3044
3 XBRL LABEL FILE abeo-20250519_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abeo-20250519_pre.xml EX-101.PRE 22378
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 25964100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)